Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics | News
Search Refinements

In Vitro Diagnostics News

View news from other Medical Devices sectors:
61-75 of 2988 results
Exosome to provide technology platforms for Merck’s drug development programs
By MDBR Staff Writer
Exosome Diagnostics has agreed to provide its technology platforms for science and technology firm Merck’s drug development programs in oncology and other therapeutic areas.
Diagnostics > In Vitro Diagnostics > News
Inova Diagnostics gets FDA approval for automated ANCA IFA assays
By MDBR Staff Writer
Inova Diagnostics has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its new immunofluorescence assays (IFA).
Diagnostics > In Vitro Diagnostics > News
EC awards €1m to breakthrough test which differentiates between viral or bacterial infections
The European Commission has awarded €1m to breakthrough test which distinguishes between viral or bacterial infections.
Diagnostics > In Vitro Diagnostics > News
Baebies gets FDA nod for metabolic disorders screening system in newborns
Baebies has secured approval from the US Food and Drug Administration (FDA) to market its newborn screening system for detection of four lysosomal storage disorders (LSDs).
Diagnostics > In Vitro Diagnostics > News
Meridian Bioscience launches TruQuick rapid tests for Asia Pacific markets
By MDBR Staff Writer
Meridian Bioscience has introduced TruQuick rapid tests for Asia Pacific and other emerging markets.
Diagnostics > In Vitro Diagnostics > News
Specific Technologies wins NIH grant to develop diagnostic system for tuberculosis
By MDBR Staff Writer
Specific Technologies has secured a $3m small business innovation research (SBIR) grant from the National Institutes of Health (NIH) to develop a novel diagnostic system for tuberculosis (TB).
Diagnostics > In Vitro Diagnostics > News
Exosome Diagnostics launches early access program for Shahky exosome protein interrogation instrument
Exosome Diagnostics has launched early access program for its point of care protein biomarker liquid biopsy instrument.
Diagnostics > In Vitro Diagnostics > News
Courtagen introduces new gene tests for neurology and endocrinology
By MDBR Staff Writer
Molecular information firm Courtagen Life Sciences has introduced 17 new gene tests for neurology and endocrinology.
Diagnostics > In Vitro Diagnostics > News
FDA clears Abbott's molecular test to detect Zika Virus in whole blood samples
The US Food and Drug Administration (FDA) has extended its emergency use authorization for Abbott's molecular test for the Zika virus for use with whole blood samples.
Diagnostics > In Vitro Diagnostics > News
Great Basin Scientific completes clinical trial and submits FDA 510(k) application for Bordetella direct test
Great Basin Scientific, (GBSN), a molecular diagnostics company, announced the completion of the clinical trial and 510(k) submission to the Food and Drug Administration (FDA) of its Bordetella direct test.
Diagnostics > In Vitro Diagnostics > News
Personal Genome Diagnostics wins NCI contract to devlop novel diagnostic for immuno-oncology drugs
By MDBR Staff Writer
Personal Genome Diagnostics (PGDx) has secured an SBIR contract from the National Cancer Institute (NCI) to develop a novel diagnostic for immuno-oncology drugs.
Diagnostics > In Vitro Diagnostics > News
GenePOC announces product launch in Europe and Middle East
GenePOC, a member of the Debiopharm Group, has announced that it has started the commercialization of its first two CE-IVD marked tests, GenePOC CDiff and GenePOC GBS assays on the revogene platform that recently obtained CE-IVD marking.
Diagnostics > In Vitro Diagnostics > News
Grifols acquires Hologic’s blood screening unit for $1.85bn
By MDBR Staff Writer
Healthcare firm Grifols has completed the acquisition of Hologic’s blood screening business for around $1.85bn.
Diagnostics > In Vitro Diagnostics > News
Ampersand Capital Partners and 1315 capital to acquire Genoptix
Ampersand Capital Partners and 1315 Capital have entered into a definitive agreement to acquire the commercial laboratory of Genoptix, a Novartis company that specializes in oncology diagnostics and informatics services.
Diagnostics > In Vitro Diagnostics > News
Ampersand Capital Partners, 1315 capital to acquire Genoptix
Ampersand Capital Partners and 1315 Capital have entered into a definitive agreement to acquire the commercial laboratory of Genoptix, a Novartis company that specializes in oncology diagnostics and informatics services.
Diagnostics > In Vitro Diagnostics > News
61-75 of 2988 results